- Home
- BCRX vs DAC Comparison
BCRX vs DAC Comparison
Compare BCRX & DAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- DAC
- Stock Information
- Founded
- BCRX 1986
- DAC 1972
- Country
- BCRX United States
- DAC Greece
- Employees
- BCRX N/A
- DAC N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- DAC Marine Transportation
- Sector
- BCRX Health Care
- DAC Consumer Discretionary
- Exchange
- BCRX Nasdaq
- DAC Nasdaq
- Market Cap
- BCRX 1.7B
- DAC 1.6B
- IPO Year
- BCRX 1994
- DAC 2006
- Fundamental
- Price
- BCRX $10.75
- DAC $85.14
- Analyst Decision
- BCRX Buy
- DAC Strong Buy
- Analyst Count
- BCRX 8
- DAC 1
- Target Price
- BCRX $16.75
- DAC $105.00
- AVG Volume (30 Days)
- BCRX 6.8M
- DAC 76.2K
- Earning Date
- BCRX 05-05-2025
- DAC 05-13-2025
- Dividend Yield
- BCRX N/A
- DAC 3.99%
- EPS Growth
- BCRX N/A
- DAC N/A
- EPS
- BCRX N/A
- DAC 24.48
- Revenue
- BCRX $503,485,000.00
- DAC $1,013,968,000.00
- Revenue This Year
- BCRX $36.61
- DAC $2.95
- Revenue Next Year
- BCRX $13.19
- DAC N/A
- P/E Ratio
- BCRX N/A
- DAC $3.48
- Revenue Growth
- BCRX 41.67
- DAC 3.10
- 52 Week Low
- BCRX $5.92
- DAC $65.40
- 52 Week High
- BCRX $11.11
- DAC $98.25
- Technical
- Relative Strength Index (RSI)
- BCRX 64.20
- DAC 56.90
- Support Level
- BCRX $10.46
- DAC $83.39
- Resistance Level
- BCRX $11.00
- DAC $85.32
- Average True Range (ATR)
- BCRX 0.41
- DAC 1.90
- MACD
- BCRX -0.02
- DAC -0.34
- Stochastic Oscillator
- BCRX 77.78
- DAC 35.33
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About DAC Danaos Corporation
Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include, HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia-Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.